Arcadia Biosciences (RKDA) Misses Q4 EPS by 2c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• Accenture downgraded by TD Cowen on AI concerns